Phathom Pharmaceuticals, Inc. (PHAT) Tops Q1 EPS by 9c

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q1 EPS of ($1.11), $0.09 better than the analyst estimate of ($1.20). Revenue for the quarter came in at $1.91 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08